MedTrace Logo

DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke

NCT05139147 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-08-09

No results posted yet for this study

Summary

The study is a prospective, multi-center, single arm, feasibility study that will enroll a maximum of 36 subjects. The maximum enrollment is 10 subjects per site. A maximum of 6 investigational centers in Europe will participate. Enrollment is expected to take about 9 months, subject participation will last about 3 months.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

DAISe Thrombectomy System

DAISe Thrombectomy System for mechanical thrombectomy

Sponsors & Collaborators

  • MIVI Neuroscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Christophe Cognard, MD, PhD · University Hospital, Toulouse

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-12
Primary Completion
2023-07-20
Completion
2023-08-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05139147 on ClinicalTrials.gov